GET THE LATEST UPDATES
Receive the latest event information about key speakers, sponsorship opportunities and exhibiting.
November 9-11, 2020 | Virtual Conference
Molly Burich, MS, is the Head of Public Policy at Boehringer Ingelheim, Inc. In her role she leads the public policy team at Boehringer with specific focus on biosimilars, oncology, pipeline products as well as reimbursement across the existing and pipeline portfolio for Boehringer Ingelheim. Ms. Burich has held previous positions in federal and state government affairs, public policy and reimbursement across other organizations including Otsuka Pharmaceuticals, Xcenda, an Amerisource Bergen company and Avalere Health. Ms. Burich holds a master of science in public service management with an emphasis in public policy from DePaul University and a bachelor of arts in political science from the University of Northern Colorado.